Variation in ERAP2 has opposing effects on severe respiratory infection and autoimmune disease

Fergus Hamilton, Alexander Mentzer, Tom Parks, J Kenneth Baillie, George Davey Smith, Peter Ghazal, Nicholas J Timpson
doi: https://doi.org/10.1101/2022.11.04.22281942

Article Information

doi 
https://doi.org/10.1101/2022.11.04.22281942
History 
  • November 5, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Fergus Hamilton1,2,*,
  2. Alexander Mentzer4,
  3. Tom Parks4,5,
  4. J Kenneth Baillie6,
  5. George Davey Smith1,
  6. Peter Ghazal7 and
  7. Nicholas J Timpson1,3
  1. 1MRC Integrative Epidemiology Unit, University of Bristol
  2. 2Infection Science, North Bristol NHS Trust
  3. 3Population Health Sciences, Bristol Medical School, University of Bristol
  4. 4Wellcome Centre For Human Genetics, University of Oxford
  5. 5Department of Infectious Disease, Imperial College London
  6. 6Roslin Institute, University of Edinburgh
  7. 7Project Sepsis, Cardiff University
  1. ↵* Corresponding author; email: fergus.hamilton{at}bristol.ac.uk
Back to top
Posted November 05, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Variation in ERAP2 has opposing effects on severe respiratory infection and autoimmune disease
Fergus Hamilton, Alexander Mentzer, Tom Parks, J Kenneth Baillie, George Davey Smith, Peter Ghazal, Nicholas J Timpson
medRxiv 2022.11.04.22281942; doi: https://doi.org/10.1101/2022.11.04.22281942
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area